Volume 78, Issue 8, Pages (October 2010)

Slides:



Advertisements
Similar presentations
Volume 63, Issue 2, Pages (February 2003)
Advertisements

Volume 81, Issue 2, Pages (January 2012)
Volume 74, Issue 12, Pages (December 2008)
Volume 82, Issue 9, Pages (November 2012)
Volume 54, Issue 2, Pages (August 1998)
Volume 63, Issue 2, Pages (February 2003)
Volume 67, Issue 6, Pages (June 2005)
Figure 3 Comparison of approaches to isolate extracellular vesicles
Tamm-Horsfall protein and urinary exosome isolation
Volume 66, Issue 5, Pages (November 2004)
Volume 82, Issue 5, (September 2012)
Volume 86, Issue 2, Pages (August 2014)
Propofol-related green urine
Sushrut S. Waikar, Venkata S. Sabbisetti, Joseph V. Bonventre 
CD24 is a marker of exosomes secreted into urine and amniotic fluid
Analysis of CDCP1 as a potential prostate cancer biomarker.
Volume 70, Issue 10, Pages (November 2006)
Characterization of proteinuria and tubular protein uptake in a new model of oral L-lysine administration in rats  K. Thelle, E.I. Christensen, H. Vorum,
Mycophenolate mofetil treatment for primary glomerular diseases
Volume 74, Issue 12, Pages (December 2008)
Volume 80, Issue 10, Pages (November 2011)
Peter Rossing, Philip Hougaard, Hans-Henrik Parving 
Volume 85, Issue 4, Pages (April 2014)
Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation  Visith Thongboonkerd, Kenneth R. Mcleish,
Volume 79, Issue 5, Pages (March 2011)
Volume 54, Issue 2, Pages (August 1998)
Rutger J.H. Maas, Jack F.M. Wetzels, Jeroen K.J. Deegens
Volume 73, Issue 4, Pages (February 2008)
Immunosuppressive treatment of focal segmental glomerulosclerosis: lessons from a randomized controlled trial  Jeroen K.J. Deegens, Jack F.M. Wetzels 
Serum-soluble urokinase receptor concentration in primary FSGS
Methotrexate in the urine
Volume 74, Issue 3, Pages (August 2008)
Volume 63, Issue 4, Pages (April 2003)
Volume 76, Issue 3, Pages (August 2009)
Volume 57, Issue 1, Pages (January 2000)
Volume 59, Issue 4, Pages (April 2001)
Volume 74, Issue 5, Pages (September 2008)
Volume 85, Issue 5, Pages (May 2014)
Volume 61, Issue 1, Pages (January 2002)
Volume 53, Issue 5, Pages (May 1998)
Volume 81, Issue 12, Pages (June 2012)
Fractional clearance of high molecular weight proteins in conscious rats using a continuous infusion method  Melissa J. Burne, Tanya M. Osicka, Wayne.
Volume 76, Issue 6, Pages (September 2009)
Capturing the in vivo molecular signature of the podocyte
Volume 72, Issue 12, Pages (December 2007)
Volume 85, Issue 3, Pages (March 2014)
Volume 74, Issue 8, Pages (October 2008)
Volume 84, Issue 5, Pages (November 2013)
Volume 78, Issue 5, Pages (September 2010)
Volume 69, Issue 8, Pages (April 2006)
Clonal spread of staphylococci among patients with peritonitis associated with continuous ambulatory peritoneal dialysis  Tor Monsen, Carin Olofsson,
Volume 71, Issue 4, Pages (February 2007)
Volume 58, Issue 5, Pages (November 2000)
Nosratola D. Vaziri, M.D., Kaihui Liang  Kidney International 
Volume 67, Issue 6, Pages (June 2005)
Volume 80, Issue 10, Pages (November 2011)
Volume 74, Issue 9, Pages (November 2008)
Volume 80, Issue 10, Pages (November 2011)
Reduced content of α subunit of Gq protein content in monocytes of Bartter and Gitelman syndromes: Relationship with vascular hyporeactivity  Lorenzo.
Volume 70, Issue 3, Pages (August 2006)
Membranous nephropathy: recent travels and new roads ahead
Dana V. Rizk, David G. Warnock  Kidney International 
Volume 63, Issue 2, Pages (February 2003)
Hisataka Kobayashi, Peter L. Choyke  Kidney International 
Volume 62, Issue 5, Pages (November 2002)
Prediction in idiopathic membranous nephropathy
Volume 80, Issue 10, Pages (November 2011)
Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases  Martina Franz, Wolfgang Woloszczuk,
Peggy W. G. du Buf-Vereijken, MD, Amanda J. W. Branten, MD, Jack F. M
Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis  Eero O. Honkanen, Anna-Maija Teppo, Carola.
Presentation transcript:

Volume 78, Issue 8, Pages 810-816 (October 2010) Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome  Ilse M. Rood, Jeroen K.J. Deegens, Michael L. Merchant, Wim P.M. Tamboer, Daniel W. Wilkey, Jack F.M. Wetzels, Jon B. Klein  Kidney International  Volume 78, Issue 8, Pages 810-816 (October 2010) DOI: 10.1038/ki.2010.262 Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 1 One-dimensional gel electrophoresis showing the difficulty of isolating microvesicular proteins from nephrotic syndrome. Isolation by (a) the nanomembrane concentrator. Lane 1, retentate; lane 2, proteins remaining on the nanomembrane after the retentate was removed and washed with Laemmli buffer; and (b) the ultracentrifugation method. The abundant protein at 73kDa was identified as albumin. Spot numbers refer to the numbers in Supplementary Table S1, where mass spectrometric data are presented. The urine sample was obtained from a patient with membranous nephropathy (protein concentration of 3.7g/l; protein excretion 5.2g per 24h). Kidney International 2010 78, 810-816DOI: (10.1038/ki.2010.262) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 2 One-dimensional gel electrophoresis of urine from a normal control showing coprecipitation of albumin with exosomes after ultracentrifugation.Lane 1, normal urine; lane 2, normal urine with 0.4% bovine serum albumin (BSA) added; lane 3, normal urine with 1% BSA. Ultracentrifugation of urine with nephrotic-range concentrations of albumin resulted in coprecipitation of albumin (lanes 2 and 3 at 73 and 150kDa, respectively) with the exosomes. Kidney International 2010 78, 810-816DOI: (10.1038/ki.2010.262) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 3 Chromatogram obtained after size-exclusion chromatography. Chromatogram of (a) urine sample from a patient with membranous nephropathy (protein concentration 10.6g/l; protein excretion 17.7g per 24h). (b) Urine sample from a patient with focal segmental glomerulosclerosis (protein concentration 7.3g/l; protein excretion 7.2g per 24h). (c) Urine sample from a normal control. A lower molecular weight fraction with a retention time of 8–12min (a) or 9–12min (b) is present in the urine obtained from patients with nephrotic-range proteinuria. Kidney International 2010 78, 810-816DOI: (10.1038/ki.2010.262) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 4 One-dimensional gel electrophoresis of proteins isolated by ultracentrifugation followed by size-exclusion chromatography. (a) High molecular weight fraction (retention time 5–8min). (b) Lower molecular weight fraction (retention time 8–10min). Spot numbers refer to the numbers in Supplementary Table S2, where mass spectrometric data are presented. The urine sample was obtained from a patient with idiopathic membranous nephropathy (protein concentration 10.6g/l; protein excretion 17.7g per 24h). Kidney International 2010 78, 810-816DOI: (10.1038/ki.2010.262) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 5 Electron microscopic image of urinary microvesicles. Urinary microvesicles were obtained by ultracentrifugation followed by size-exclusion chromatography. (a) Sample from a patient with idiopathic membranous nephropathy (protein concentration 4.4g/l; protein excretion 7.5g per 24h). (b) Sample from a patient with focal segmental glomerulosclerosis (protein concentration 6.0g/l; protein excretion 19.4g per 24h). Kidney International 2010 78, 810-816DOI: (10.1038/ki.2010.262) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 6 Efficiency of urinary microvesicle isolation by ultracentrifugation (lane 1), nanomembrane ultrafiltration (lane 2), ultracentrifugation followed by size-exclusion chromatography (high molecular weight fraction, lane 3), and ultracentrifugation followed by size-exclusion chromatography (lower molecular weight fraction, lane 4). Western blot analysis was performed for neprilysin, aquaporin-2, and albumin. (a) Urine sample from a patient with idiopathic membranous nephropathy (protein concentration 4.4g/l; protein excretion 7.5g per 24h). (b) Urine sample from a patient with focal segmental glomerulosclerosis (protein concentration 6.0g/l; protein excretion 19.4g per 24h). Kidney International 2010 78, 810-816DOI: (10.1038/ki.2010.262) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 7 Efficiency of urinary microvesicle isolation by ultracentrifugation followed by size-exclusion chromatography (high molecular weight fraction, lane 1), ultracentrifugation followed by removal of Tamm–Horsfall protein from the 200,000g pellet with dithiothreitol (DTT) and reultracentrifugation (lane 2). Western blot analysis was performed for podocalyxin and albumin. Pooled urine sample from three patients with idiopathic membranous nephropathy (median protein concentration 4.6 (range 3.1–4.6)g/l; median protein excretion 5.0 (3.5–6.3)g per 24h). Kidney International 2010 78, 810-816DOI: (10.1038/ki.2010.262) Copyright © 2010 International Society of Nephrology Terms and Conditions